e-learning
resources
Glasgow 2004
Wednesday 08.09.2004
Inflammation and remodelling in human lungs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Factor XIIIa is expressed in etiologically different fibrotic pulmonary lesions
C. C. Van Leer, J. Zbaeren, M. Gugger, C. Obregon, V. Schroeder, L. P. Nicod, T. K. Geiser (Bern, Switzerland)
Source:
Annual Congress 2004 - Inflammation and remodelling in human lungs
Session:
Inflammation and remodelling in human lungs
Session type:
Oral Presentation
Number:
4181
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. C. Van Leer, J. Zbaeren, M. Gugger, C. Obregon, V. Schroeder, L. P. Nicod, T. K. Geiser (Bern, Switzerland). Factor XIIIa is expressed in etiologically different fibrotic pulmonary lesions. Eur Respir J 2004; 24: Suppl. 48, 4181
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Inhalation of activated recombinant factor VII to treat pulmonary hemorrhage in a patient with cystic fibrosis
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF
Source: Eur Respir J 2001; 17: 1220-1227
Year: 2001
Correlation between tenascin C and tissue factor in patients with interstitial lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 83s
Year: 2003
B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion.
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Procoagulant and antifibrynolitic activities strongly correlate with fibrosis and tissue turn-over markers in patients with active idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Coagulation factor XII regulates inflammatory responses in human lungs
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
The protease activated receptor (PAR)-2/tissue factor/coagulation factor VIIa axis in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Pulmonary expression of alternatively spliced tissue factor as a potential prognostic marker in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 25s
Year: 2002
Expression of CD 34 and von Willebrand factor in pulmonary endothelium
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001
Features of pulmonary involvement in patients with diffuse connective tissue diseases
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
Fibroblastic foci in IPF are non-proliferative and express GATA-6
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010
¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Down regulation of stromal cell-derived factor 1 (SDF-1/CXCL12) in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
P-Smad2 and α-SMA are co-localized in fibroblastic foci of human idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis
Source: ERJ Open Res, 6 (4) 00347-2020; 10.1183/23120541.00347-2020
Year: 2020
Features of pulmonary involvement in patients with diffuse connective tissue diseases depending on a nosological form
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
Role of vascular endotelial growth factor polymorphisms in interstitial lung disease
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept